{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Episode 36 - Brandon Rice and IND Submission with AI","description":"My guest in this episode is Brandon Rice. Brandon is the CEO and co-founder at Weave Bio, a software company focused on automating regulatory submissions in the pharmaceutical industry using AI where he oversees product development, specifically leading the creation of AutoIND, their AI-powered platform for IND preparation. &amp;nbsp; In this conversation, Brandon discusses his journey to co-founding Weave Bio. He highlights the challenges of regulatory compliance, the potential of AI to streamline processes, and the importance of human oversight in AI-generated content. The discussion also touches on the cultural differences in AI adoption among pharmaceutical companies, global regulatory trends, and the need for open-mindedness towards new technologies. I thoroughly enjoyed my chat with Brandon and learned a lot about the current AI in pharma landscape. I hope you do too. Here's Brandon Rice. ","author_name":"The Future of Pharma","author_url":"https:\/\/www.ispeboston.org\/","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/38253570\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/193157325"}